Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...

Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing ...

We came across a bullish thesis on Atea Pharmaceuticals, Inc. (AVIR) on Substack by Turtles Research. In this article, we ...

HCV screening of pregnant and nonpregnant women in the US are increasing but remain suboptimal suggesting the need for ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular ...

Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January 2025, Atea is initiating a global Phase 3 program and expects patient ...

Results Patients with hepatitis B (HBV) were more likely to develop HCC at a younger age than patients with hepatitis C (HCV) (HBV-26% under age 40, HCV-0% under age 40; p < 0.001), with greater ...

Please provide your email address to receive an email when new articles are posted on . HCV screening increased after guidelines updated to screen all adults and during each pregnancy. Screening ...

Atea Pharmaceuticals (AVIR) announced the poster presentation of bemnifosbuvir preclinical data at the 38th International Conference on ...

Israel to fight on in Gaza for 'as long as the hostages are not returned': minister Fujirebio Europe today announced the availability* of the INNO-LiPA HCV 2.0 Genotyping assay. The product, ...